$1.60
-0.62%
N/A-$0.01
Healthcare
Biotechnology
AMEX
활발히 거래 중
CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Its flagship immunotherapy ...
CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Its flagship immunotherapy ...
| 날짜 | 임원 | 직책 | 증권 | 구분 | 주식 수 | 가격 |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | KERSTEN GEERT R | director, officer: Chief Executive Officer | Common Stock | A | 100,000 | $1.38 |
| Aug 14, 2026 | Watson Robert Eugene | director | Options | A | 110,000 | $1.49 |
| Aug 14, 2026 | BAILLAVOINE BRUNO JEAN-MARIE | director | Options | A | 110,000 | $1.49 |
| Aug 14, 2026 | CIPRIANO JOHN | officer: Senior Vice President | Options | A | 80,000 | $1.49 |
| Aug 14, 2026 | TALOR EYAL | officer: Chief Scientific Officer | Options | A | 250,000 | $1.49 |
매수/매도 주식 수와 종가 추세(공통 일간 가격 소스)
X축: 주식 수, 총 주식 수 내림차순
X축: 건수, A+D 건수 내림차순
| 날짜 | 임원 | 직책 | 증권 | 구분 | 주식 수 | 가격 | 금액 |
|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | KERSTEN GEERT R | director, officer: Chief Executive Officer | Common Stock | A | 100,000 | $1.38 | $138,000.00 |
| Aug 14, 2026 | Watson Robert Eugene | director | Options | A | 110,000 | $1.49 | $163,900.00 |
| Aug 14, 2026 | BAILLAVOINE BRUNO JEAN-MARIE | director | Options | A | 110,000 | $1.49 | $163,900.00 |
| Aug 14, 2026 | CIPRIANO JOHN | officer: Senior Vice President | Options | A | 80,000 | $1.49 | $119,200.00 |
| Aug 14, 2026 | TALOR EYAL | officer: Chief Scientific Officer | Options | A | 250,000 | $1.49 | $372,500.00 |
| Aug 14, 2026 | PRICHEP PATRICIA B | officer: Chief Financial Officer | Options | A | 225,000 | $1.49 | $335,250.00 |
| Aug 14, 2026 | KERSTEN GEERT R | director, officer: Chief Executive Officer | Options | A | 300,000 | $1.49 | $447,000.00 |
| Jun 30, 2026 | TALOR EYAL | officer: Chief Scientific Officer | Common Stock | A | 2,307 | $1.04 | $2,399.28 |
| Jun 30, 2026 | PRICHEP PATRICIA B | officer: Chief Financial Officer | Common Stock | A | 4,125 | $1.04 | $4,290.00 |
| Jun 30, 2026 | KERSTEN GEERT R | director, officer: Chief Executive Officer | Common Stock | A | 5,192 | $1.04 | $5,399.68 |